TNF gene polymorphism as a risk factor that can cause arterial hypertension in patients suffering from gastroesophageal reflux disease

View or download the full article: 
616.329-002-02: 616.33-008.17]-06: [616.12-008.331.1-02: 575.174.015.3

O.V. Khlynova1, E.A. Shishkina1, V. Sakhena1, A.V. Krivtsov2, G.N. Spasenkov3, N.I. Abgaryan3


1Perm State Medical University named after Academician E.A. Wagner, 26 Petropavlovskaya Str., Perm, 614000, Russian Federation
2Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya Str., Perm, 614045, Russian Federation
3Cardiologic Clinic, 8 Sibirskaya Str., Perm, 614002, Russian Federation


Comorbidity of arterial hypertension (AH) and gastroesophageal reflux disease (GERD) is widely spread (from 20.6 % to 29 %); despite that fact, risk factors that can cause AH in patients suffering from GERD have still not been examined completely. Experts are discussing a role played by anti-inflammation cytokine of tumor necrosis factor alpha (TNF) both in AH occurrence and GERD pathogenesis as it is its activity that is to a great extent determined by a patient having certain alleles of tumor necrosis factor (TNF) gene. Therefore, it seems vital to study TNF gene G308A polymorphism in patients with combined AH and GERD.
Our research goal was to study frequency and variants of TNF gene G308A polymorphism relations with AH risk and AH phenotypic peculiarities in patients suffering from GERD.
We examined 58 people who had AH (29 patients with isolated AH, average age being 53 [46; 62], and 29 patients with combined AH and GERD, average age being 56 [51; 59]). Patients from both groups were comparable in terms of sex, age, and examined factors of cardiovascular diseases risks. We applied allele-specific polymerase reaction with test systems produced by “Sintol” LLC (Moscow) to determine G308A (rs1800629) polymorphism of TNF gene. To assess relations between alleles and genotypes and disease risks, we calculated odds ratio (OR) with 95 % confidence interval (CI).
We revealed a relation between G308A polymorph marker of TNF gene and systolic blood pressure and disorders in tolerance to dextrose among patients with comorbid AH and GERD. Patients with combined AH and GERD had unfavorable allele A and G/A genotype authentically more frequently (OR 5.14; 95 % CI – 1.06–24.95; р = 0.03, OR 6.08; 95 % CI – 1.18–31.25; р = 0.02 accordingly).
We showed that G308A polymorphism was related to AH occurrence in patients suffering from GERD. These data confirm that endothelial dysfunction plays a significant role in AH pathogenesis among such patients.

arterial hypertension, gastroesophageal reflux disease, comorbidity, endothelial dysfunction, risk factor, genetic polymorphism, TNF gene, arterial hypertension phenotype.
Khlynova O.V., Shishkina E.A., Sakhena V., Krivtsov A.V., Spasenkov G.N., Abgaryan N.I. TNF gene polymorphism as a risk factor that can cause arterial hypertension in patients suffering from gastroesophageal reflux disease. Health Risk Analysis, 2020, no. 1, pp. 126–132. DOI: 10.21668/health.risk/2020.1.14.eng
  1. Forouzanfar M.H., Liu P., Roth G.A., Ng M., Biryukov S., Marczak L., Alexander L., Estep K. [et al.]. Global Burden of Hypertension and Systolic Blood Pressureofat Least 110 to 115 mm Hg, 1990–2015. JAMA, 2017, vol. 317, no. 2, pp. 165–182. DOI: 10.1001/jama.2016.19043
  2. Boitsov S.A., Balanova Yu.A., Shal'nova S.A., Deev A.D., Artamonova G.V., Gatagonova T.M., Duplyakov D.V., Efanov A.Yu. [et al.]. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Kardiovaskulyarnaya terapiya i profilaktika, 2014, vol. 13, no. 4, pp. 4–14 (in Russian).
  3. Vertkin A.L., Rumyantsev M.A., Skotnikov A.S. Komorbidnost' v klinicheskoi praktike. Chast' 1 [Comorbidity in clinical practice. Part I.]. Arkhiv vnutrennei meditsiny, 2011, no. 1, pp. 16–20 (in Russian).
  4. Lazebnik L.B., Masharova A.A., Bordin D.S., Vasil'ev Yu.V., Tkachenko E.I., Abdulkhakov R.A., Butov M.A., Er-emina E.Yu. [et al.]. Results of a multicenter trial «Epidemiology of Gastroesophageal Reflux Disease in Russia» (MEGRE). Terapevticheskii arkhiv, 2011, vol. 83, no. 1, pp. 45–50 (in Russian).
  5. Comorbidities are Frequent in Patients with Gastroesophageal Reflux Disease in a Tertiary Health Care Hospital Arti-cle in Clinics (São Paulo, Brazil). Sci. Elo., 2009, vol. 64, no. 8, pp. 785–790. Available at: http: // S1807-59322009000800013&lng=en&nrm=iso (29.07.2019).
  6. Kusche-Vihrog K., Urbanova K., Blanqué A., Wilhelmi M., Schillers H., Kliche K., Pavenstädt H., Brand E., Ober-leithner H. C-reactive protein makes human endothelium stiff and tight. Hypertension, 2011, vol. 57, no. 2, pp. 231–237. DOI: 10.1161/HYPERTENSIONAHA.110.163444
  7. Babbitt D.M., Kim J.S., Forrester S.J., Brown M.D., ParkJ.Y. Effect of Interleukin-10 and laminar shear stress on en-dothelial nitric oxide synthase and nitric oxide in African American human umbilical vein endothelial cells. Ethnicity and Disease, 2015, vol. 25, no. 4, pp. 413–418. DOI: 10.18865/ed.25.4.413
  8. Chazova I.E., Ratova L.G., Boitsov S.A., Nebieridze D.V., Karpov Yu.A., Belousov Yu.B., Volkova E.G., Galyavich A.S. [et al.]. Diagnostika i lechenie arterial'noi gipertenzii (Rekomendatsii Rossiiskogo meditsinskogo obshchestva po arterial'noi gipertonii i Vserossiiskogo nauchnogo obshchestva kardiologov) [Arterial hypertension: diagnostics and treatment (recom-mendations by the Russian Medical Society for Arterial Hypertension Studies of the Russian Scientific Society of Cardiologists) ]. Sistemnye gipertenzii, 2010, no. 3, pp. 5–26 (in Russian).
  9. Kaibysheva V.O., Kucheryavyi Yu.A., Trukhmanov A.S., Storonova O.A., Kon'kov M.Yu., Maev I.V., Ivashkin V.T. Results of multicenter observation study on application of international questionnaire GerdQ for diagnostics of gastroesophageal reflux disease. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii, 2013, vol. 23, no. 5, pp. 15–23 (in Russian).
  10. Ivashkin V.T., Maev I.V., Trukhmanov A.S., Baranskaya E.K., Dronova O.B., Zairat'yants O.V., Saifutdinov R.G., Sheptulin A.A. Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii, 2017, vol. 27, no. 4, pp. 75–95 (in Russian).
  11. Timasheva Ya.R., Nasibullin T.R., Zakirova A.N., Mustafina O.E. Tumor necrosis factor alpha gene polymorphism in patients with essential hypertension. Kardiovaskulyarnaya terapiya i profilaktika, 2007, vol. 6, no. 6, pp. 5–9 (in Russian).
  12. Li Y.Y. Tumor necrosis factor-alpha G308α gene polymorphism and essential hypertension: a meta-analysis involving 2244 participants. Plos One, 2012, vol. 7, no. 4, pp. e35408. DOI: 10.1371/journal.pone.0035408
  13. Zhao Y., Li Z., Zhang L., Zhang Y., Yang Y., Tang Y., Fu P. The TNF-alpha –308G/A polymorphism is associated with type 2 diabetes mellitus: an updated meta-analysis. Molecular. Biology Reports., 2014, no. 41, pp. 73–83. DOI: 10.1007/s11033-013-2839-1
  14. Sookoian S., Garcií S.I., Gianotti T.F., Dieuzeide G., González C.D., Pirola C.J. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with hypertension in adolescents harboring the metabolic syndrome. American Journal of Hypertension, 2005, vol. 18, no. 10, pp. 1271–1275. DOI: 10.1016/j.amjhyper.2005.04.014
  15. Sbarsi I., Falcone C., Boiocchi C., Campo I., Zorzetto M., De Silvestri A., Cuccia M. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. International Journal of Immunopathology and Pharmacology, 2007, vol. 20, no. 1, pp. 145–154. DOI: 10.1177/039463200702000117
  16. Zhang P., Wu X., Li G., He Q., Dai H., Ai C., Shi J. Tumor necrosis factor-alpha gene polymorphisms and susceptibility to ischemic heart disease: A systematic review and meta-analysis. Medicine (Baltimore), 2017, vol. 95, no. 14, pp. e6569. DOI: 10.1097/MD.0000000000006569
  17. Brazhnik V.A., Minushkina L.O., Averkova A.O. Polymorphism of TNF gene in acute coronary syndrome patients: data from the registries oracle I and oracle II. Rossiiskii kardiologicheskii zhurnal, 2018, vol. 23, no. 10, pp. 23–27 (in Russian).
  18. Cheng H., Chang C.S., Wang H.J., Wang W.C. Interleukin 1β and 10 polymorphisms influence erosive reflux esoph-agitis and gastritis in Taiwanese patients. Journal of Gastroenterology and Hepatology, 2010, vol. 25, no.8, pp. 1443–1451. DOI: 10.1111/j.1440-1746.2010.06310.x
  19. Yang F., Wei K., Qin Z., Shao C., Shu Y., Shen H. Association between TNF--308G/A polymorphism and esophageal cancer risk: An updated meta-analysis and trial sequential analysis. Journal of Cancer, 2019, vol. 10, no. 5, pp. 1086–1096. DOI: 10.7150/jca.29390
  20. Haider S.H., Kwon S., Lam R. Predictive Biomarkers of Gastroesophageal Reflux Disease and Barrett’s Esophagus in World Trade Center Exposed Firefighters: a 15 Year Longitudinal Study. Scientific Reports, 2018, no. 8, pp. 3106. DOI: 10.1038/s41598-018-21334-9
  21. Peng D.F., Hu T.L., Soutto M., Belkhiri A., El-Rifai W. Loss of glutathione peroxidase 7 promotes TNF alpha induced NF kappaB activation in Barrett’s carcinogenesis. Carcinogenesis, 2014, no. 35, pp. 1620–1628. DOI: 10.1093/carcin/bgu083
  22. Martens F.M., Rabelink T.J., Op't Roodt J., De Koning E.J.P., Visseren F.L.G. TNF-alpha induces endothelial dys-function in diabetic adults, an effect reversible by the PPAR-gamma agonist pioglitazone. European Heart Journal, 2006, vol. 27, no. 13, pp. 1605–1609. DOI: 10.1093/eurheartj/ehl079

You are here